Brief: Samsung Epis Holdings Says Unit Samsung Bioepis Entered Into Exclusive Supply Agreement Under Brazilian Government Programme For Rare-Disease Treatment
Yesterday 02:50
BRIEF-Samsung Epis Holdings Says Unit Samsung Bioepis Entered Into Exclusive Supply Agreement Under Brazilian Government Programme For Rare-Disease Treatment Oct 21 (Reuters) - Samsung Epis Holdings Co Ltd 0126Z0.KS:
UNIT SAMSUNG BIOEPIS ENTERED INTO EXCLUSIVE SUPPLY AGREEMENT UNDER BRAZILIAN GOVERNMENT PROGRAMME FOR RARE-DISEASE TREATMENT SB12, A BIOSIMILAR TO SOLIRIS
Further company coverage: 0126Z0.KS
(Reporting by Joyce Lee)
((JungYoon.Lee@thomsonreuters.com;))
Recent news on Samsung Epis Holdings
See all newsBrief: Samsung Epis Holdings Says Unit Samsung Bioepis Entered Into Exclusive Supply Agreement Under Brazilian Government Programme For Rare-Disease Treatment
Brief: Samsung Bioepis, Teva Expand Strategic Partnership To Advance Up To 6 Potential Biosimilar Candidates
Brief: Samsung Epis Holdings Co Applies To Korea Food Ministry For Approval Of Pembrolizumab Biosimilar
Brief: Samsung Epis Holdings Co Q2 Operating Profit 86.6 Billion Won, Down 3.6% Y/Y